Sarah Kim is a Partner at Clayton, Dubilier & Rice (CD&R), a leading global private equity firm, where she invests in healthcare and has played key roles in many of the firm’s transactions. Prior to CD&R, she held positions at Metalmark Capital and McCown De Leeuw, both private equity firms, and began her career in the investment banking division of Goldman, Sachs & Co. She currently serves as a member of the Board of Directors of naviHealth as well as on the Advisory Board of the Harvard Association for Law and Business. She received a B.A. in economics and political science from Yale University, a J.D. from Harvard Law School and an M.B.A from Harvard Business School.